Cover ImageSALE
市場調查報告書

全球醫療影像用試劑市場:2017∼2021年

Global Medical Imaging Reagents Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 574594
出版日期 內容資訊 英文 95 Pages
訂單完成後即時交付
價格
Back to Top
全球醫療影像用試劑市場:2017∼2021年 Global Medical Imaging Reagents Market 2017-2021
出版日期: 2017年10月30日 內容資訊: 英文 95 Pages
簡介

醫療影像用試劑是在特定的內臟器官,組織,疾病,和生理學的功能使用醫療用影像設備的疾病診斷和監測製作)物質。使用X光掃描,CT,超音波,SPECT,PET,MRI等廣泛的顯像模式。預計全球醫療影像用試劑市場2017∼2021年以8.57%的CAG擴大。

本報告提供全球醫療影像用試劑市場相關調查,市場現狀與未來的預測,各產品、各地區的趨勢,及加入此市場的主要供應商的簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各產品市場區隔

  • 概要
  • 顯影劑
  • 核子醫學攝影試劑

第7章 各地區市場區隔

  • 概要
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第8章 決策架構

第9章 促進要素與課題

第10章 市場趨勢

第11章 供應商環境

  • 競爭環境

第12章 主要供應商分析

  • Bayer
  • Bracco Diagnostics
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging
  • 其他值得注意的供應商

第13章 附錄

目錄
Product Code: IRTNTR14974

About Medical Imaging Reagents

Medical imaging reagents are substances that are designed to enhance the imaging of specific organs, tissues, diseases, and physiological functions using medical imaging equipment to diagnose and monitor diseases. Medical imaging reagents are used in a wide range of imaging modalities such as X-ray, computed tomography (CT), ultrasound, single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI). Imaging reagents have improved the quality of medical imaging examinations.

Technavio's analysts forecast the global medical imaging reagents market to grow at a CAGR of 8.57% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global medical imaging reagents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Medical Imaging Reagents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bayer
  • Bracco Diagnostics
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging

Other Prominent Vendors

  • Cardinal Health
  • Curium
  • DONGKOOK
  • Eli Lilly and Company
  • Isologic Innovative Radiopharmaceuticals
  • Jiangsu Hengrui Medicine
  • Piramal Imaging
  • SHINE Medical Technologies

Market driver

  • Rising incidence of cardiovascular disorders and cancer
  • For a full, detailed list, view our report

Market challenge

  • High cost of developing imaging reagents
  • For a full, detailed list, view our report

Market trend

  • Increasing number of strategic collaborations
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Overview

PART 05: Market landscape

  • Overview
  • Market size and forecast
  • Five forces analysis

PART 06: Segmentation by product type

  • Overview
  • Contrast reagents
  • Nuclear imaging reagents

PART 07: Segmentation by geography

  • Overview
  • Americas
  • EMEA
  • APAC

PART 08: Decision framework

PART 09: Drivers and challenges

  • Market drivers
  • Market challenges

PART 10: Market trends

  • Increasing number of strategic collaborations
  • Increasing number of product approvals
  • Increasing R&D focus on nanotechnology-based imaging reagents

PART 11: Vendor landscape

  • Competitive landscape

PART 12: Key vendor analysis

  • Bayer
  • Bracco Diagnostics
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging
  • Other prominent vendors

PART 13: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global medical imaging reagents market: Segmentation
  • Exhibit 02: Global medical imaging reagents market 2016-2021 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global medical imaging reagents market: Segmentation by product type 2016 (% share)
  • Exhibit 05: Global contrast reagents market 2016-2021 ($ millions)
  • Exhibit 06: Global contrast reagents market: Segmentation by product type 2016 (% share)
  • Exhibit 07: Major iodinated contrast reagents
  • Exhibit 08: Global Iodinated contrast reagents market 2016-2021($ millions)
  • Exhibit 09: Major gadolinium contrast reagents
  • Exhibit 10: Global gadolinium contrast reagents market 2016-2021 ($ millions)
  • Exhibit 11: Major microbubbles contrast reagents
  • Exhibit 12: Global microbubbles contrast reagents market 2016-2021 ($ millions)
  • Exhibit 13: Global barium-based contrast reagents market 2016-2021 ($ millions)
  • Exhibit 14: Major nuclear imaging reagents
  • Exhibit 15: Global nuclear imaging reagents market 2016-2021 ($ millions)
  • Exhibit 16: Global medical imaging reagents market: Segmentation by geography 2016 (% share)
  • Exhibit 17: Medical imaging reagents market in Americas 2016-2021 ($ millions)
  • Exhibit 18: Medical imaging reagents market in EMEA 2016-2021 ($ millions)
  • Exhibit 19: Medical imaging reagents market in APAC 2016-2021 ($ millions)
  • Exhibit 20: Number of MRI exams performed by hospitals and ASCs per 1,000 people 2013-2015
  • Exhibit 21: Number of CT exams performed by hospitals and ASCs per 1,000 people 2013-2015
  • Exhibit 22: Global medical imaging reagents market: Competitive structure analysis 2016
  • Exhibit 23: Bayer: Key highlights
  • Exhibit 24: Bayer: Strength assessment
  • Exhibit 25: Bayer: Strategy assessment
  • Exhibit 26: Bayer: Opportunity assessment
  • Exhibit 27: Bracco Diagnostics: Key highlights
  • Exhibit 28: Bracco Diagnostics: Strength assessment
  • Exhibit 29: Bracco Diagnostics: Strategy assessment
  • Exhibit 30: Bracco Diagnostics: Opportunity assessment
  • Exhibit 31: GE Healthcare: Key highlights
  • Exhibit 32: GE Healthcare: Strength assessment
  • Exhibit 33: GE Healthcare: Strategy assessment
  • Exhibit 34: GE Healthcare: Opportunity assessment
  • Exhibit 35: Guerbet Group: Key highlights
  • Exhibit 36: Guerbet Group: Strength assessment
  • Exhibit 37: Guerbet Group: Strategy assessment
  • Exhibit 38: Guerbet Group: Opportunity assessment
  • Exhibit 39: Lantheus Medical Imaging: Key highlights
  • Exhibit 40: Lantheus Medical Imaging: Strength assessment
  • Exhibit 41: Lantheus Medical Imaging: Strategy assessment
  • Exhibit 42: Lantheus Medical Imaging: Opportunity assessment
Back to Top